|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Diabetes Mellitus, Type 1 | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Diabetes Mellitus | |||||
| 3 | More general conditions related to this trial | ||||
| Autoimmune Diseases | |||||
| Endocrine System Diseases | |||||
| Glucose Metabolism Disorders | |||||
| Immune System Diseases | |||||
| Metabolic Diseases | |||||
| 4 | Additional drug interventions recognized in this trial | ||||
| Insulin | |||||
| 5 | More general drug interventions related to this trial | ||||
| Hypoglycemic Agents | |||||
| Pharmacologic Actions | |||||
| Physiological Effects of Drugs | |||||
| 6 | Sponsors listed in this trial | ||||
| National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | |||||
| National Center for Research Resources (NCRR) | |||||
| National Institute of Allergy and Infectious Diseases (NIAID) | |||||
| National Institute of Child Health and Human Development (NICHD) | |||||
| National Center on Minority Health and Health Disparities (NCMHD) | |||||
| Office of Research on Women's Health (ORWH) | |||||